Evidence map›Paper›PMID 37230168›Full record

ArticleContemporary clinical trials2023

Contingency management with stepped care for unhealthy alcohol use among individuals with HIV: Protocol for a randomized controlled trial.

E Jennifer Edelman, James Dziura, Yanhong Deng, Dominick DePhilippis, Lisa M Fucito, Tekeda Ferguson, Roger Bedimo, Sheldon Brown, Vincent C Marconi, Matthew Bidwell Goetz and 9 more

2 registry-linked trialsOpen access · greenAbstract readClinical Trial Protocol
In one paragraph

Article in Contemporary clinical trials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03089320 nacompletednot on this map

Financial Incentives, Randomization With Stepped Treatment Trial

TypeinterventionalSponsorYale UniversityRan2018 to 2023Enrolled120ConditionsUnhealthy Alcohol UseArmsContingency Management Counseling, Addiction Physician Management, Motivational Enhancement Therapy
NCT07465588 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Randomized Evaluation of Incentives FOR Clinical Effectiveness in Liver Recovery (REINFORCE Trial): A PEth-Based Contingency Management Pilot Randomized Controlled Trial for Alcohol Use Disorder in Patients With Alcohol-Associated Liver Disease

TypeinterventionalSponsorMassachusetts General HospitalRan2026 to 2028Enrolled90ConditionsAlcohol Use Disorder, Alcohol-associated Liver Disease, Liver Cirrhosis, Alcoholic, Alcohol-Associated HepatitisArmsPEth Based Contingency Management, PEth Monitoring with Fixed Incentives
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 14 institutions in 1 country.

E Jennifer EdelmanProgram in Addiction Medicine, Yale School of Medicine, New Haven, CT, USA; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA; Yale Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT, USA. Electronic address: ejennifer.edelman@yale.edu.
James DziuraYale Center for Analytic Sciences, Yale University School of Public Health, New Haven, CT, USA; Department of Emergency Medicine, Yale School of Medicine, New Haven, CT, USA.
Yanhong DengYale Center for Analytic Sciences, Yale University School of Public Health, New Haven, CT, USA.
Dominick DePhilippisVeterans Affairs Office of Mental Health and Suicide Prevention, US Department of Veterans Affairs, Washington, DC, USA; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Lisa M FucitoDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Tekeda FergusonDepartment of Epidemiology, Louisiana State University School of Public Health, New Orleans, LA, USA; Comprehensive Alcohol-HIV/AIDS Research Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
Roger BedimoVeterans Affairs North Texas Health Care System and UT Southwestern Dallas, TX, USA.
Sheldon BrownJames J. Peters Veterans Affairs Medical Center and Manhattan VA Medical Center and Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Vincent C MarconiAtlanta VAMC, Emory University School of Medicine, Rollins School of Public Health, Atlanta, GA, USA.
Matthew Bidwell GoetzVA Greater Los Angeles Healthcare System, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Maria C Rodriguez-BarradasMichael E DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, TX, USA.
Michael S SimberkoffVA NY Harbor Healthcare System and New York University Grossman School of Medicine, New York, NY, USA.
Patricia E MolinaComprehensive Alcohol-HIV/AIDS Research Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA; Department of Physiology, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
Amy C WeintrobWashington D.C. Veterans Affairs Medical Center and George Washington University, Washington, DC, USA.
Stephen A MaistoDepartment of Psychology, Syracuse University, Syracuse, NY, USA.
Manuel ParisDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Amy C JusticeDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA; VA Connecticut Healthcare System, Veterans Aging Cohort Study, West Haven, CT, USA.
Kendall J BryantNational Institute on Alcohol Abuse and Alcoholism HIV/AIDS Program, Bethesda, MD, USA.
David A FiellinProgram in Addiction Medicine, Yale School of Medicine, New Haven, CT, USA; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA; Yale Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT, USA; Department of Emergency Medicine, Yale School of Medicine, New Haven, CT, USA.
Yale University · USAtlanta VA Medical Center · USBaylor College of Medicine · USGeorge Washington University · USJames J. Peters VA Medical Center · USLouisiana State University · USLouisiana State University Health Sciences Center New Orleans · USNational Institute on Alcohol Abuse and Alcoholism · USSyracuse University · USThe University of Texas Southwestern Medical Center · USUniversity of Pennsylvania · USVA Connecticut Healthcare System · USVA Greater Los Angeles Healthcare System · USVA NY Harbor Healthcare System · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
Alcohol and Multisubstance Use in the Veterans Aging Cohort StudyU01AA020790 · NIAAA · YALE UNIVERSITY · PI JUSTICE, AMY CAROLINE · 2011 to 2020
$7.7M
The HIV and Alcohol Research center focused on Polypharmacy (HARP)P01AA029545 · NIAAA · YALE UNIVERSITY · PI JUSTICE, AMY CAROLINE · 2021 to 2025
$6.3M
Sex Disparities in Overall Response to ART Among HIV Infected IndividualsU24AA020794 · NIAAA · YALE UNIVERSITY · PI JUSTICE, AMY CAROLINE · 2011 to 2020
$5.5M
Integrated Stepped Care for Unhealthy Alcohol Use in HIVU01AA020795 · NIAAA · YALE UNIVERSITY · PI FIELLIN, DAVID · 2011 to 2020
$5.2M
NCATS NIH HHS UL1 TR001863NIAAA NIH HHS P01 AA029545NIAAA NIH HHS U01 AA020790NIAAA NIH HHS U01 AA020795NIAAA NIH HHS U24 AA020794NIAID NIH HHS P30 AI050409
6 · The paper itself

Abstract

backgroundAlthough unhealthy alcohol use is associated with increased morbidity and mortality among people with HIV (PWH), many are ambivalent about engaging in treatment and experience variable responses to treatment. We describe the rationale, aims, and study design for the Financial Incentives, Randomization, with Stepped Treatment (FIRST) Trial, a multi-site randomized controlled efficacy trial.

methodsPWH in care recruited from clinics across the United States who reported unhealthy alcohol use, had a phosphatidylethanol (PEth) >20 ng/mL, and were not engaged in formal alcohol treatment were randomized to integrated contingency management with stepped care versus treatment as usual. The intervention involved two steps; Step 1: Contingency management (n = 5 sessions) with potential rewards based on 1) short-term abstinence; 2) longer-term abstinence; and 3) completion of healthy activities to promote progress in addressing alcohol consumption or conditions potentially impacted by alcohol; Step 2: Addiction physician management (n = 6 sessions) plus motivational enhancement therapy (n = 4 sessions). Participants' treatment was stepped up at week 12 if they lacked evidence of longer-term abstinence. Primary outcome was abstinence at week 24. Secondary outcomes included alcohol consumption (assessed by TLFB and PEth) and the Veterans Aging Cohort Study (VACS) Index 2.0 scores; exploratory outcomes included progress in addressing medical conditions potentially impacted by alcohol. Protocol adaptations due to the COVID-19 pandemic are described.

conclusionsThe FIRST Trial is anticipated to yield insights on the feasibility and preliminary efficacy of integrated contingency management with stepped care to address unhealthy alcohol use among PWH. CLINICALTRIALS: gov identifier: NCT03089320.

Indexed as

COVID-19HIV InfectionsAlcohol DrinkingCohort StudiesHumansPandemicsRandomized Controlled Trials as TopicAlcoholAlgorithmsContingency managementHIVMotivational enhancement therapyMulticenter studyRandomized controlled trial

Identifiers

PMID37230168
PMCPMC10460633
OpenAlexW4377695137

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.